Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON l-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease

By Vinuela A.  

Brain, Vol. 131, Iss. 12, 2008-12 ,pp. : 3361-3379

Oxford University Press

Access to resources Recommend Favorite

Three Types of Tyrosine Hydroxylase-Positive CNS Neurons Distinguished by Dopa Decarboxylase and VMAT2 Co-Expression

By Weihe Eberhard   Depboylu Candan   Schütz Burkhard   Schäfer Martin   Eiden Lee  

Cellular and Molecular Neurobiology, Vol. 26, Iss. 4-6, 2006-07 ,pp. : 657-676

Springer Publishing Company

Access to resources Recommend Favorite

Bromocriptine Protects Dopaminergic Neurons from Levodopa-Induced Toxicity by Stimulating D 2 Receptors

By Takashima H.   Tsujihata M.   Kishikawa M.   Freed W.J.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 98-104

Elsevier

Access to resources Recommend Favorite

Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors

By Rinne J. O.   Iivanainen M.   Metsähonkala L.   Vainionpää L.   Pääkkönen L.   Någren K.   Helenius H.  

Journal of Neural Transmission, Vol. 111, Iss. 1, 2004-01 ,pp. : 59-67

Springer Publishing Company

Access to resources Recommend Favorite

Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

By Aguiar Aderbal  

Neurotoxicity Research, Vol. 24, Iss. 2, 2013-08 ,pp. : 280-287

Springer Publishing Company

Access to resources Recommend Favorite